The ADC market offers significant growth opportunities driven by the rising cancer incidence and demand for targeted therapies, which improve efficacy and reduce toxicity. Advancements in precision ...

A new HIC–MS method using ammonium tartrate improves ADC characterization, enabling efficient drug-to-antibody ratio analysis without complex workflows. A proteomics workflow combining laser ablation ...

Genentech's native HIC-MS method uses ammonium tartrate, enabling efficient MS detection without compromising chromatographic ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Discover the innovative Alco5 platform by Tubulis, advancing cancer therapies with novel antibody-drug conjugate technology.

Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, ...

Ellipses and Innolake will collaborate closely on the development of ILB-3101/EP0028, which is currently in a Phase 1 trial in China sponsored by Innolake. Ellipses will initiate a Phase 1 clinical ...

According to doctors and hospital officials, these drugs incur 8 to 12 per cent import duties, and the basic customs duty tax ...

The exemption of basic customs duty on 17 cancer drugs and the addition of seven rare diseases to the list eligible for duty-free personal imports have been widely described as a patient-first reform.

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced that it has entered into a collaboration and licence ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...